These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 31517021)
1. The acceptability of smokeless tobacco products depends on nicotine levels. Cruz-Cano R; Rangel-Gomez M; Van Wagoner C; Kidanu A; Brinkman MC; Clark PI Addict Behav Rep; 2019 Dec; 10():100217. PubMed ID: 31517021 [TBL] [Abstract][Full Text] [Related]
2. Using Electrophysiological Measures to Assess the Consumer Acceptability of Smokeless Tobacco Products. Buzzell GA; Das B; Cruz-Cano R; Nkongho LE; Kidanu AW; Kim H; Clark PI; McDonald CG Nicotine Tob Res; 2016 Sep; 18(9):1853-1860. PubMed ID: 26928479 [TBL] [Abstract][Full Text] [Related]
3. Nicotine pharmacokinetics and subjective responses after using nicotine pouches with different nicotine levels compared to combustible cigarettes and moist smokeless tobacco in adult tobacco users. Liu J; Rensch J; Wang J; Jin X; Vansickel A; Edmiston J; Sarkar M Psychopharmacology (Berl); 2022 Sep; 239(9):2863-2873. PubMed ID: 35869988 [TBL] [Abstract][Full Text] [Related]
4. Dissociating the effect of flavor and nicotine in smokeless tobacco products using electroencephalography: The case of wintergreen flavors. Rangel-Gomez M; Cruz-Cano R; Van Wagoner C; Kidanu A; McDonald CG; Clark PI Addict Behav; 2019 Apr; 91():82-89. PubMed ID: 30553545 [TBL] [Abstract][Full Text] [Related]
5. Exposure to nicotine and carcinogens among Southwestern Alaskan Native cigarette smokers and smokeless tobacco users. Benowitz NL; Renner CC; Lanier AP; Tyndale RF; Hatsukami DK; Lindgren B; Stepanov I; Watson CH; Sosnoff CS; Jacob P Cancer Epidemiol Biomarkers Prev; 2012 Jun; 21(6):934-42. PubMed ID: 22490317 [TBL] [Abstract][Full Text] [Related]
6. Self-Administration of Smokeless Tobacco Products in Rats. LeSage MG; Burroughs D; Muelken P; Harris AC Tob Regul Sci; 2016 Oct; 2(4):329-342. PubMed ID: 28239627 [TBL] [Abstract][Full Text] [Related]
7. The pH of Smokeless Tobacco Determines Nicotine Buccal Absorption: Results of a Randomized Crossover Trial. Wilhelm J; Mishina E; Viray L; Paredes A; Pickworth WB Clin Pharmacol Ther; 2022 May; 111(5):1066-1074. PubMed ID: 34826137 [TBL] [Abstract][Full Text] [Related]
8. Animal models to assess the abuse liability of tobacco products: effects of smokeless tobacco extracts on intracranial self-stimulation. Harris AC; Tally L; Schmidt CE; Muelken P; Stepanov I; Saha S; Vogel RI; LeSage MG Drug Alcohol Depend; 2015 Feb; 147():60-7. PubMed ID: 25561387 [TBL] [Abstract][Full Text] [Related]
9. Pilot study on lower nitrosamine smokeless tobacco products compared with medicinal nicotine. Mendoza-Baumgart MI; Tulunay OE; Hecht SS; Zhang Y; Murphy S; Le C; Jensen J; Hatsukami DK Nicotine Tob Res; 2007 Dec; 9(12):1309-23. PubMed ID: 18058349 [TBL] [Abstract][Full Text] [Related]
10. Evidence supporting product standards for carcinogens in smokeless tobacco products. Hatsukami DK; Stepanov I; Severson H; Jensen JA; Lindgren BR; Horn K; Khariwala SS; Martin J; Carmella SG; Murphy SE; Hecht SS Cancer Prev Res (Phila); 2015 Jan; 8(1):20-6. PubMed ID: 25524878 [TBL] [Abstract][Full Text] [Related]
11. Comparison of Urinary Biomarkers of Exposure in Humans Using Electronic Cigarettes, Combustible Cigarettes, and Smokeless Tobacco. Lorkiewicz P; Riggs DW; Keith RJ; Conklin DJ; Xie Z; Sutaria S; Lynch B; Srivastava S; Bhatnagar A Nicotine Tob Res; 2019 Aug; 21(9):1228-1238. PubMed ID: 29868926 [TBL] [Abstract][Full Text] [Related]
12. Nicotine delivery, cardiovascular profile, and subjective effects of an oral tobacco product for smokers. Blank MD; Sams C; Weaver MF; Eissenberg T Nicotine Tob Res; 2008 Mar; 10(3):417-21. PubMed ID: 18324559 [TBL] [Abstract][Full Text] [Related]
13. Nicotine quantity and packaging disclosure in smoked and smokeless tobacco products in India. Sharma P; Murthy P; Shivhare P Indian J Pharmacol; 2015; 47(4):440-3. PubMed ID: 26288479 [TBL] [Abstract][Full Text] [Related]
15. Smokeless tobacco products sold in Massachusetts from 2003 to 2012: trends and variations in brand availability, nicotine contents and design features. Cullen D; Keithly L; Kane K; Land T; Paskowsky M; Chen L; Hayes R; Li W Tob Control; 2015 May; 24(3):256-62. PubMed ID: 24420311 [TBL] [Abstract][Full Text] [Related]
16. Exposure to a Tobacco-Specific Carcinogen Among Adolescent Smokeless Tobacco Users in Rural California, United States. Chaffee BW; Jacob P; Couch ET; Benowitz NL Nicotine Tob Res; 2020 Oct; 22(10):1764-1771. PubMed ID: 31504879 [TBL] [Abstract][Full Text] [Related]
17. Smokeless tobacco abstinence effects and nicotine gum dose. Hatsukami D; Anton D; Keenan R; Callies A Psychopharmacology (Berl); 1992; 106(1):60-6. PubMed ID: 1738794 [TBL] [Abstract][Full Text] [Related]
18. Nicotine pharmacokinetics and subjective effects of three potential reduced exposure products, moist snuff and nicotine lozenge. Kotlyar M; Mendoza-Baumgart MI; Li ZZ; Pentel PR; Barnett BC; Feuer RM; Smith EA; Hatsukami DK Tob Control; 2007 Apr; 16(2):138-42. PubMed ID: 17400953 [TBL] [Abstract][Full Text] [Related]
19. Delivery of nicotine in an extract of a smokeless tobacco product reduces its reinforcement-attenuating and discriminative stimulus effects in rats. Harris AC; Stepanov I; Pentel PR; Lesage MG Psychopharmacology (Berl); 2012 Apr; 220(3):565-76. PubMed ID: 21960181 [TBL] [Abstract][Full Text] [Related]
20. Chemical and toxicological characteristics of conventional and low-TSNA moist snuff tobacco products. Song MA; Marian C; Brasky TM; Reisinger S; Djordjevic M; Shields PG Toxicol Lett; 2016 Mar; 245():68-77. PubMed ID: 26802282 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]